CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.

Appendix cancer cases are increasing among young adults. Know the causes, warning signs, types, diagnosis methods, and modern ...

The Central Drugs Standard Control Organisation (CDSCO) has granted approval for Durvalumab in combination with FLOT ...

AstraZeneca receives CDSCO approval for Durvalumab, enhancing treatment options for resectable gastric cancer in India.

Nasopharyngeal carcinoma (NPC) has emerged as a defining cancer challenge for Nagaland, with the state recording the highest incidence in India among both men and women, according to Dr KeveduyiTheyo, ...

Nagaland records India’s highest nasopharyngeal cancer incidence, with tobacco use, diet and late diagnosis driving high ...

Dave Coulier revealed he’s in remission after undergoing treatment for tongue cancer. The “Full House” actor first shared his ...

In a recent study, a team of scientists discovered that a treatment using different medications was found to be effective to ...

February 2026 Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers Recommendation based on MATTERHORN Phase III trial ...

Up to 40 percent of cancer cases worldwide are preventable, the World Health Organization (WHO) said Tuesday. In a joint news ...

Channing Tatum shared he had to undergo surgery over a separated shoulder, sharing x-ray images of the injury before and ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, "Henlius") announced today the conclusion of an ...